Tu1739 – Efficacy and Safety of Ustekinumab Through Week 16...

Gastroenterology 2019 / 05 Vol. 156; Iss. 6

Tu1739 – Efficacy and Safety of Ustekinumab Through Week 16 in Patients with Moderate to Severe Ulcerative Colitis Randomized to Ustekinumab: Results from the Unifi Induction Trial

Danese, Silvio, Sands, Bruce E., O'Brien, Christopher D., Zhang, Hongyan, Johanns, Jewel, Sloan, Sheldon, Izanec, James L., Szapary, Philippe, Marano, Colleen W., Leong, Rupert W., Rowbotham, David, T
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
156
Language:
english
Journal:
Gastroenterology
DOI:
10.1016/S0016-5085(19)39725-2
Date:
May, 2019
File:
PDF, 808 KB
english, 2019
Conversion to is in progress
Conversion to is failed